CME and CFTC Engage in Heated Battle Over On-Chain Perpetual Futures

The conflict between the CME Group and the US Commodity Futures Trading Commission (CFTC) has escalated, with the CME suing the CFTC over its decision to allow the listing of blockchain-based perpetual futures products. The CME claims that these products, which enable users to speculate on asset prices with leverage and no expiration date, are being mislabeled and that the CFTC is misapplying the law. The CFTC has approved the listing of these products, including those offered by Kalshi and Coinbase, despite the CME's objections. The dispute has significant implications for the US approach to the rapidly growing market for perpetual futures, with non-US volume reportedly reaching $60 trillion last year. The CME argues that the CFTC's sudden embrace of perpetual futures did not consider the potential consequences and that these products are harmful to its long-dated futures products. The CFTC, on the other hand, believes that its decision to allow the listing of perpetual futures is a necessary step to promote innovation and competition in the market. The case is currently awaiting federal court action, which could have a significant impact on the future of the US derivatives market. The CME's lawsuit argues that the CFTC's decision to allow perpetual futures is a deviation from the law and that the products are not properly regulated. The CFTC, however, believes that its decision is consistent with its regulatory framework and that the products are subject to adequate oversight. The dispute has sparked a heated debate, with some arguing that the CME is trying to stifle innovation and competition, while others believe that the CFTC is failing to properly regulate the market. The outcome of the case will have significant implications for the US derivatives market and the future of perpetual futures.